HK1177200A1 - 格隆氯銨的晶型 - Google Patents
格隆氯銨的晶型Info
- Publication number
- HK1177200A1 HK1177200A1 HK13104051.3A HK13104051A HK1177200A1 HK 1177200 A1 HK1177200 A1 HK 1177200A1 HK 13104051 A HK13104051 A HK 13104051A HK 1177200 A1 HK1177200 A1 HK 1177200A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- crystal form
- glycopyrronium chloride
- glycopyrronium
- chloride
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10165786 | 2010-06-14 | ||
| PCT/EP2011/002893 WO2011157387A1 (en) | 2010-06-14 | 2011-06-13 | Crystal form of glycopyrronium chloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1177200A1 true HK1177200A1 (zh) | 2013-08-16 |
Family
ID=42751657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13104051.3A HK1177200A1 (zh) | 2010-06-14 | 2013-04-02 | 格隆氯銨的晶型 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9174937B2 (zh) |
| EP (1) | EP2580195B1 (zh) |
| KR (1) | KR101736529B1 (zh) |
| CN (1) | CN102939280B (zh) |
| AR (1) | AR081889A1 (zh) |
| BR (1) | BR112012031451A2 (zh) |
| CA (1) | CA2802584C (zh) |
| ES (1) | ES2528957T3 (zh) |
| HK (1) | HK1177200A1 (zh) |
| RU (1) | RU2569852C2 (zh) |
| WO (1) | WO2011157387A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6114841B2 (ja) | 2013-02-28 | 2017-04-12 | ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． | グリコピロレート塩 |
| US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| EP3293176B1 (en) | 2013-10-22 | 2020-12-02 | Chiesi Farmaceutici S.p.A. | Crystal form of a pde4 inhibitor |
| US9926270B2 (en) | 2014-08-20 | 2018-03-27 | Dermira, Inc. | Process for production of glycopyrronium tosylate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
| RU2238936C2 (ru) * | 1996-11-11 | 2004-10-27 | Кристиан Р. НОЕ | Энантиомерно чистые основные эфиры арил-циклоалкилгидроксикарбоновых кислот, способ их получения и применение в лекарственных средствах |
| US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| AT412088B (de) * | 2002-12-18 | 2004-09-27 | Pharmacon Forschung & Beratung Gmbh | Verfahren zur herstellung der r,r oder s,s konfigurierten glycopyrronium-isomere |
| US20070185067A1 (en) * | 2004-02-27 | 2007-08-09 | Altana Pharma Ag | Ciclesonide and glycopyrronium combination |
| EP1616567A1 (en) * | 2004-07-16 | 2006-01-18 | Boehringer Ingelheim Pharma GmbH & Co.KG | Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts |
| GB0504463D0 (en) * | 2005-03-03 | 2005-04-13 | Arakis Ltd | Method of crystallisation and purification |
| US7915303B2 (en) * | 2005-03-24 | 2011-03-29 | Sosei R&D Ltd. | Glycopyrronium salts and their therapeutic use |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| EP1894568A1 (en) * | 2006-08-31 | 2008-03-05 | Novartis AG | Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| KR101290893B1 (ko) * | 2009-04-09 | 2013-07-29 | 노파르티스 아게 | 피롤리디늄 염의 제조 방법 |
-
2011
- 2011-06-13 WO PCT/EP2011/002893 patent/WO2011157387A1/en active Application Filing
- 2011-06-13 EP EP11735781.4A patent/EP2580195B1/en active Active
- 2011-06-13 AR ARP110102059A patent/AR081889A1/es unknown
- 2011-06-13 KR KR1020127032332A patent/KR101736529B1/ko active IP Right Grant
- 2011-06-13 CA CA2802584A patent/CA2802584C/en active Active
- 2011-06-13 RU RU2012154006/04A patent/RU2569852C2/ru active
- 2011-06-13 CN CN201180029241.3A patent/CN102939280B/zh active Active
- 2011-06-13 ES ES11735781.4T patent/ES2528957T3/es active Active
- 2011-06-13 BR BR112012031451A patent/BR112012031451A2/pt not_active Application Discontinuation
- 2011-06-14 US US13/159,922 patent/US9174937B2/en active Active
-
2013
- 2013-04-02 HK HK13104051.3A patent/HK1177200A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2580195A1 (en) | 2013-04-17 |
| US20110305645A1 (en) | 2011-12-15 |
| KR101736529B1 (ko) | 2017-05-17 |
| AR081889A1 (es) | 2012-10-24 |
| CA2802584A1 (en) | 2011-12-22 |
| RU2012154006A (ru) | 2014-07-20 |
| US9174937B2 (en) | 2015-11-03 |
| EP2580195B1 (en) | 2014-12-03 |
| ES2528957T3 (es) | 2015-02-13 |
| CA2802584C (en) | 2018-08-21 |
| CN102939280B (zh) | 2014-11-19 |
| BR112012031451A2 (pt) | 2016-12-06 |
| CN102939280A (zh) | 2013-02-20 |
| KR20130119844A (ko) | 2013-11-01 |
| RU2569852C2 (ru) | 2015-11-27 |
| WO2011157387A1 (en) | 2011-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100005I1 (hu) | Metiltioninium-klorid | |
| HK1210172A1 (zh) | 二螺吡咯烷衍生物的晶體 | |
| EP2656340A4 (en) | DISPLAY AREA UPDATE | |
| HK1178149A1 (zh) | 吡唑- -基-雜環基-甲酰胺化合物及其使用方法 | |
| DE102011055858A8 (de) | Flüssigkristallanzeige | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| HK1179605A1 (zh) | 酰胺化合物晶體 | |
| IL213973A0 (en) | Salt of tetrahydrotriazolopyridine derivative and crystal thereof | |
| HK1177200A1 (zh) | 格隆氯銨的晶型 | |
| GB2486481B (en) | Display surround | |
| HK1251217A1 (zh) | 穩定的dotap氯化物晶體變體 | |
| PT2558201T (pt) | Branqueamento de substratos | |
| HRP20181375T1 (hr) | Novi kristalni oblici | |
| ZA201209488B (en) | Crystal of thienopyrimidine derivative | |
| HK1210143A1 (zh) | 氮雜環丁烷酮化合物的晶型及其製備方法 | |
| HK1160777A1 (en) | Novel use of neohesperidoside | |
| GB201018482D0 (en) | Crystal structure of isoglutaminyl cyclase | |
| GB201021429D0 (en) | Crystal structure | |
| GB201006722D0 (en) | Crystal structure | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| EP2602253A4 (en) | CRYSTAL OF AN ANTIBACTERIAL CONNECTION | |
| ZA201105238B (en) | Levelling of supports | |
| TWM401033U (en) | Improved engaging structure of light steel frame | |
| TWM401050U (en) | Combination structure of frame | |
| TWM390745U (en) | Structure improvement of tea-making can |